7 recruiting, 2 active not recruiting, 2 enrolling by invitation, 2 not yet recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
| Not applicable | 1 | Recruiting 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow IPMN, Pancreatic: new trials by email Literature Review of IPMN, Pancreatic trials Research Report on IPMN, Pancreatic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Venous Resection in Patients Undergoing Pancreatic Surgery IPMN, Pancreatic, Pancreatic Cancer, Resected | Not yet recruiting | Sahlgrenska University Hospital | 1000 | 2026-06-01 | 2026-06-02 | |
| AI-Powered Precision Decision-Making for Pancreatic Diseases Diagnosis by Artificial Intelligence model - Pancreatic Cancer, Diagnose Disease | Recruiting | Changhai Hospital | 2000 | 2026-03-01 | 2026-02-27 | |
| Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA) HOP bundle - Pancreas Head Cancer, Pancreas Adenocarcinoma | Phase 4 | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 400 | 2025-09-01 | 2025-12-22 |
| Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer Diagnostic procedures - Diabetes, IPMN, Pancreatic | Not applicable | Recruiting | Fondazione Policlinico Universitario Campus Bio-Medico | 400 | 2025-09-01 | 2026-06-22 |
| Impact of GLP-1 Receptor Agonists on Patients With IPMN GLP1 receptor agonist - IPMN, IPMN, Pancreatic | Not yet recruiting | Hôpital Fribourgeois | 30 | 2025-05-31 | 2025-06-11 | |
| Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression Blood Collection Protocol for Patients with Indolent, Invasive, and Pancreatic Cancer-Associated IPMN Based on Clinical Course and Surgical Intervention - IPMN, Pancreatic | Recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 3600 | 2025-05-29 | 2025-09-03 | |
| Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium IPMN, Pancreatic | Recruiting | IRCCS San Raffaele | 800 | 2025-01-03 | 2025-11-19 | |
| The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas) LINFU® - IPMN, Pancreatic, Pancreas Cancer | Enrolling by invitation | Adenocyte, LLC | 500 | 2024-10-15 | 2026-08-06 | |
| Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3) Vitamin E Delta Tocotrienol, Placebo - Neoplasm of Pancreas, IPMN, Pancreatic | Phase 2 | Active not recruiting | H. Lee Moffitt Cancer Center and Research Institute | 4 | 2024-07-09 | 2025-11-13 |
| Pancreatic Cancer Initial Detection Via Liquid Biopsy Liquid biopsy - Pancreatic Cancer, IPMN, Pancreatic | Enrolling by invitation | Karolinska University Hospital | 200 | 2024-05-01 | 2024-04-24 | |
| A Long-term Follow-up Cohort Study in Patients With Intraductal Papillary Mucinous Neoplasm Endoscopic ultrasound - IPMN, Pancreatic | Unknown | Peking Union Medical College Hospital | 1500 | 2022-12-01 | 2022-11-14 | |
| Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer IPMN, Pancreatic, IPMN | Recruiting | St Vincent's Hospital Melbourne | 1000 | 2021-08-26 | 2024-04-18 | |
| The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) Sulindac 400 MG, Placebo - IPMN, IPMN, Pancreatic | Phase 2 | Active not recruiting | Duke University | 100 | 2020-07-10 | 2026-09-08 |
| Advanced Therapies for Liver Metastases Pancreatic Ductal Adenocarcinoma (PDAC), Colorectal Cancer (CRC) | Recruiting | IRCCS San Raffaele | 625 | 2019-11-06 | 2026-04-06 |
Pancreatic Intraductal Neoplasms (14) · Pancreatic Neoplasms (6) · Pancreatitis, Chronic (3) · Diabetes Mellitus (2) · Pancreatic Cyst (2) · Pancreatitis (2) · Adenoma, Islet Cell (1) · Colorectal Neoplasms (1) · Duodenal Neoplasms (1) · Fistula (1) · Pancreatic Diseases (1) · Smoking (1)
Digestive System Diseases (14) · Digestive System Neoplasms (14) · Endocrine Gland Neoplasms (14) · Endocrine System Diseases (14) · Neoplasms (14) · Neoplasms by Histologic Type (14) · Neoplasms by Site (14) · Neoplasms, Ductal, Lobular, and Medullary (14) · Neoplasms, Glandular and Epithelial (14) · Pancreatic Diseases (13) · Pancreatic Neoplasms (8) · Pathological Conditions, Signs and Symptoms (4) · Chronic Disease (3) · Disease Attributes (3) · Pathologic Processes (3)
Diagnostic Techniques and Procedures (1) · Endosonography (1) · Hydrocortisone (1) · Liquid Biopsy (1) · Octreotide (1) · Sulindac (1) · Surgical Procedures, Operative (1) · tocotrienol, delta (1)
IRCCS San Raffaele (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Adenocyte, LLC (1) · Changhai Hospital (1) · Duke University (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Fondazione Policlinico Universitario Campus Bio-Medico (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Hôpital Fribourgeois (1) · Karolinska University Hospital (1) · Peking Union Medical College Hospital (1) · Sahlgrenska University Hospital (1) · St Vincent's Hospital Melbourne (1)
Italy (4) · United States (3) · Netherlands (2) · Sweden (2) · Australia (1) · China (1) · Switzerland (1)
Adrian Fox (1) · Carmine Carbone, PhD (1) · Chiara Bonini, MD (1) · Gregory Haber, MD FRCP (1) · Mokenge P Malafa, MD, FACS (1) · Peter Allen, MD (1) · Shengyu Zhang, M.D. (1) · Xi Wu, M.D. (1) · Yiran Su, MD candidate (1)
PMID 28735806, PMID 30196428, PMID 38182527, PMID 38230766, PMID 38553466, PMID 42715243
R01CA235677 (1), R01CA263575 (1)